Israel Englander’s Guardant Health GH Stock Holding History

Israel Englander’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$625K	–	6170
2025 Q3	$625K	Sell	10,000 -3,800	-28%	-$207K	﹤0.01%	4939
2025 Q2	$718K	Sell	13,800 -245,100	-95%	-$10.9M	﹤0.01%	4653
2025 Q1	$11M	Buy	258,900 +223,400	+629%	+$9.64M	0.01%	2079
2024 Q4	$1.08M	Sell	35,500 -139,300	-80%	-$3.92M	﹤0.01%	4137
2024 Q3	$4.01M	Buy	+174,800	New	+$4.95M	﹤0.01%	3041
2023 Q2	–	Sell	-10,000	Closed	-$234K	–	6310
2023 Q1	$234K	Buy	+10,000	New	+$286K	﹤0.01%	5081
2021 Q3	–	Sell	-7,500	Closed	-$931K	–	6947
2021 Q2	$931K	Sell	7,500 -11,100	-60%	-$1.49M	﹤0.01%	4731
2021 Q1	$2.84M	Buy	+18,600	New	+$2.81M	﹤0.01%	3188

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Israel Englander's GH Position: Q2 2026 in Review

Israel Englander increased its Guardant Health (GH) stake by 76% in Q2 2026, buying an estimated $76.2M and bringing the position to 1,622,458 shares worth $243M. The position accounts for 0.09% of the portfolio, ranked #186.

Israel Englander first reported a position in GH in Q2 2019 and has held it in 26 quarters since. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Israel Englander held 1,622,458 shares of Guardant Health worth $243M as of Q2 2026.
Israel Englander bought 701,063 Guardant Health shares in Q2 2026, an estimated $76.2M.
Guardant Health made up 0.09% of Israel Englander's portfolio in Q2 2026, its #186 holding.
Israel Englander first reported a position in Guardant Health in Q2 2019 and has held it in 26 quarters since.
595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.